Abstract
Background A 25-year-old male presented to his local urologist with new-onset right testicular pain and swelling detected on self examination. A scrotal ultrasound scan showed a right testicular mass, suspicious for neoplasm. Serum levels of α-fetoprotein and human chorionic gonadotropin were found to be elevated at 920.2 µg/l and 637.4 U/l, respectively. The patient underwent right inguinal orchiectomy and was diagnosed with nonseminomatous germ cell tumor of the right testis, composed of yolk sac tumor, teratoma, and embryonal carcinoma with no evidence of metastatic disease. He opted to remain under surveillance rather than undergo primary chemotherapy or retroperitoneal lymph node dissection for his clinical stage I disease. Serologic relapse at 4 months after orchiectomy was successfully treated with bleomycin, etoposide and cisplatin (BEP) chemotherapy.
Investigations Surveillance comprised regular clinic visits, measurement of serum levels of α-fetoprotein, human chorionic gonadotropin and lactate dehydrogenase, chest X-ray and CT of the abdomen and pelvis. Pathology of the testicular mass was reviewed.
Diagnosis A 1.7 cm nodule anterior to the right psoas muscle suspicious for metastatic disease that was seen on CT 16 months after orchiectomy was pathologically confirmed as recurrent mature teratoma in the spermatic cord. Additionally, one of eleven interaortocaval lymph nodes showed evidence of teratoma.
Management Bilateral nerve-sparing retroperitoneal lymph node dissection with complete excision of the right spermatic cord was performed. The patient has since remained disease-free, with normal levels of serum tumor markers and no evidence of metastasis on chest X-ray and abdominal CT.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Freedman LS et al. (1987) Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet 2: 294–298
Choueiri TK et al. (2007) Management of clinical stage I nonseminomatous germ cell testicular cancer. Urol Clin North Am 34: 137–148
Warde P et al. (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol 20: 4448–4452
Peckham MJ et al. (1982) Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet 2: 678–680
Yoon GH et al. (2005) Retroperitoneal lymph node dissection in the treatment of low-stage nonseminomatous germ cell tumors of the testicle: an update. Urol Oncol 23: 168–177
Lashley DB et al. (1998) A rational approach to managing stage I nonseminomatous germ cell cancer. Urol Clin North Am 25: 405–423
Rustin GJ et al. (2007) Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197—the National Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol 25: 1310–1315
Chang SS et al. (2002) Paracolic recurrence: the importance of wide excision of the spermatic cord at retroperitoneal lymph node dissection. J Urol 167: 94–96
Kantzavelos L et al. (2003) Paracolic recurrence of stage I seminomas [abstract]. Urology 62: 145
Daugaard G et al. (2006) Inguinal metastases from testicular cancer. BJU Int 97: 724–726
Debono DJ et al. (1997) Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors. J Clin Oncol 15: 1455–1464
Oldenburg J et al. (2003) Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual masses. J Clin Oncol 21: 3310–3317
Spiess PE et al. (2007) Surgical management of growing teratoma syndrome: the MD Anderson Cancer Center experience. J Urol 177: 1330–1334
Beck SDW et al. (2002) Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer. J Urol 168: 1402–1404
Carver BS et al. (2006) Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection. J Urol 176: 100–104
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Subramanian, V., Gilligan, T. & Klein, E. A case of spermatic cord teratoma in low-stage testicular cancer managed by surveillance. Nat Rev Urol 5, 220–223 (2008). https://doi.org/10.1038/ncpuro1048
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpuro1048